GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with fat.
Experts are now turning their attention toward helping GLP-1 patients maintain muscle while dropping fat, according to a pair of new studies presented at the American Diabetes Association's annual meeting in Chicago.
An experimental muscle-preserving drug called bimagrumab helped people taking semaglutide (Ozempic/Wegovy) keep their muscle while losing weight, according to clinical trial results presented Monday.
In a separate study presented Sunday, researchers unveiled a potential test for tracking weight loss among GLP-1 patients.
Related
